CCN2 and non-small cell lung carcinoma: These indicated that ALKBH5 directly binds to YAP pre-mRNA, decreases its m6A modification and reduces the expressions of YAP, CTGF and Cyr61, through which need the ALKBH5 catalytic activity in NSCLC.